Healthcare -
Biotechnology - NASDAQ - US
$ 9.25
-0.213 %
$ 646 M
Market Cap
-0.91
P/E
PHAT - SHORT-TERM DEBT
Short-term Debt PHAT - Phathom Pharmaceuticals, Inc.
501 K
LAST VALUE
-40.52%
2 YEAR CAGR
9.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR